Culture Biosciences Raises $80M Series B to Tackle Demand for Large-Scale Biomanufacturing
Culture is closing the gap in manufacturing capacity with its large-scale cloud bioreactors
27-Oct-2021 -
Culture Biosciences, a company enabling biotech firms to develop and scale manufacturing processes in the cloud, announced a Series B financing of $80 million led by Northpond Ventures. Synthesis Capital also participated in the round. Existing investors Cultivian Sandbox Ventures, The Production ...
biopharmaceutical manufacturing
bioprocessing
bioreactors
+2